What regulatory guidelines apply to 4-[(4-Methyl-1-piperazinyl)methyl]-N-(6-methyl-5-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}-3-pyridinyl)-3-(trifluoromethyl)benzamide methanesulfonate (1:1) (CAS: 895519-91-2)?

Regulatory guidelines for 4-[(4-Methyl-1-piperazinyl)methyl]-N-(6-methyl-5-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}-3-pyridinyl)-3-(trifluoromethyl)benzamide methanesulfonate (1:1) (CAS: 895519-91-2) include GHS classification, REACH regulations, and FDA/EPA requirements. Under GHS, it is classified as a hazardous substance due to its potential for causing skin and eye irritation. REACH regulations require manufacturers and importers to register and manage the risks associated with its production and use. FDA and EPA regulations focus on its safety in pharmaceutical and environmental contexts.